| Dr Kevin Taylor Mcmurtrie, PHARMD | |
|
5606 Inverness Pl, Northport, AL 35473-1438 | |
| (205) 218-9948 | |
| Not Available |
| Full Name | Dr Kevin Taylor Mcmurtrie |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 5606 Inverness Pl, Northport, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457727760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18677 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Taylor Mcmurtrie, PHARMD 5606 Inverness Pl, Northport, AL 35473-1438 Ph: (205) 218-9948 | Dr Kevin Taylor Mcmurtrie, PHARMD 5606 Inverness Pl, Northport, AL 35473-1438 Ph: (205) 218-9948 |
News Archive
Total cholesterol, triglycerides and C-reactive protein levels are among 11 risk factors for heart attack that remained greatly reduced up to seven years after gastric bypass surgery, according to a new Stanford University study presented here at the 29th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.
Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) being held in Orlando this week. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The U.S. Food and Drug Administration today granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes.
There is growing evidence that caregivers of patients with cardiovascular disease are vulnerable to developing their own poor cardiovascular health.
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing Alzheimer's disease for diabetic patients, and reduced insulin levels in the brain tissue of Alzheimer's disease patients. Though intriguing, the existing evidence does not reveal if defective insulin signaling is causative of Alzheimer's or how insulin resistance impacts cognitive function.
› Verified 9 days ago
Daniel Lee Webber, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 Fax: 205-333-1544 | |
Dr. Jessica Jo Salvatore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5710 Mcfarland Blvd, Northport, AL 35476 Phone: 205-333-7873 | |
Nicholas Matthew Witucki, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Casey Rasinen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Dr. Zachary Grant Hunt, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Jann Sides, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-0155 Fax: 205-339-1316 | |
Dr. Robert Meaders Bragg, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-2700 |